257
Participants
Start Date
March 31, 2006
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
HB-AS02V
HB-AS02V (20µg HBsAg) will be administered at Month 0 and 1
HBVAXPRO vaccine
HBVAXPRO vaccine (40µg HBsAg) will be administered at Month 0 and 1
Cliniques universitaires Saint Luc, Brussels
UZ Gasthuisberg Leuven Nierziekten, Leuven
CHU Hôpital civil de, Charleroi
CHU Andre VESALE, Montigny-le-Tilleul
CHU Tivoli, La Louvière
RHMS Clinique Louis Caty Baudour, Baudour
RHMS TournayService de néphrologie, Tournai
RHMS La Madeleine ATH, Ath
UZ Gent, Ghent
O.L.Vrouwziekenhuis Aalst, Aalst
CHU Brugmann (site V Horta) Service de néphrologie, Brussels
ULB Hôpital Erasme Département de Néphrologie, Brussels
UZ AntwerpenDienst nefrologie, Edegem
Clinic of Gerontology and MetabolismDepartment of NephrologyUniversity HospitalSokolska, Hradec Králové
Dept. of Heamodialysis Hospital JihlavaVrchlického, Jihlava
Dept. of NephrologyIII. Clinic of Internal DiseasesUniversity Hospital I.P.Pavlova, Olomouc
Infection Diseases and AIDS Treatment ClinicUniversity Hospital with Outpatient Clinic, Ostrava - Poruba
Fresenius Medical Care - DS, s.r.o.: PardubiceDialysis Unit Kyjevska, Pardubice
Fresenius Medical Care - DS, s.r.o.: SokolovDialysis Unit Slovenska, Sokolov
University of Debrecen Medical and Science CenterI. Medical Clinic for Internal Diseases Nephrology Department, Debrecen
Markhot Ferenc County HospitalFresenius Dialysis Center Baktai, Eger
Vaszary Kolos HospitalFresenius Dialysis Center, Esztergom
Petz Aladár Teaching Hospital Vasvári, Győr
Hatvan Hospital Health Care ProviderFresenius Dialysis Center Hatvan ., Hatvan
Zala County HospitalII. Medical Department Nephrology Zrinyi, Zalaegerszeg
Lead Sponsor
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Henogen
INDUSTRY